Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q.

Potrony M, Puig-Butille JA, Farnham JM, Giménez-Xavier P, Badenas C, Tell-Martí G, Aguilera P, Carrera C, Malvehy J, Teerlink CC, Puig S.

Eur J Hum Genet. 2018 Apr 30. doi: 10.1038/s41431-018-0149-8. [Epub ahead of print]

PMID:
29706638
2.

Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching study.

Boada A, Tejera-Vaquerizo A, Ribero S, Puig S, Moreno-Ramírez D, Descalzo-Gallego MA, Fierro MT, Quaglino P, Carrera C, Malvehy J, Vidal-Sicart S, Bennássar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla Á, Fernández-Figueras MT, Ferrándiz C, Pascual I, Manzano JL, Sánchez-Lucas M, Giménez-Xavier P, Ferrandiz L, Nagore E.

Int J Cancer. 2018 Feb 1;142(3):641-648. doi: 10.1002/ijc.31078. Epub 2017 Oct 13.

PMID:
28960289
3.

Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.

Vallone MG, Tell-Marti G, Potrony M, Rebollo-Morell A, Badenas C, Puig-Butille JA, Gimenez-Xavier P, Carrera C, Malvehy J, Puig S.

Pigment Cell Melanoma Res. 2018 Jan;31(1):39-50. doi: 10.1111/pcmr.12646. Epub 2017 Oct 17.

PMID:
28950052
4.

Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells.

Gimenez-Xavier P, Pros E, Bonastre E, Moran S, Aza A, Graña O, Gomez-Lopez G, Derdak S, Dabad M, Esteve-Codina A, Hernandez Mora JR, Salinas-Chaparro D, Esteller M, Pisano D, Sanchez-Cespedes M.

Mol Cancer Ther. 2017 Jul;16(7):1366-1376. doi: 10.1158/1535-7163.MCT-17-0104. Epub 2017 Apr 10.

5.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Pereira C, Gimenez-Xavier P, Pros E, Pajares MJ, Moro M, Gomez A, Navarro A, Condom E, Moran S, Gomez-Lopez G, Graña O, Rubio-Camarillo M, Martinez-Martí A, Yokota J, Carretero J, Galbis JM, Nadal E, Pisano D, Sozzi G, Felip E, Montuenga LM, Roz L, Villanueva A, Sanchez-Cespedes M.

Clin Cancer Res. 2017 Jun 15;23(12):3203-3213. doi: 10.1158/1078-0432.CCR-16-1946. Epub 2017 Mar 16.

6.

IRF4 rs12203592 functional variant and melanoma survival.

Potrony M, Rebollo-Morell A, Giménez-Xavier P, Zimmer L, Puig-Butille JA, Tell-Marti G, Sucker A, Badenas C, Carrera C, Malvehy J, Schadendorf D, Puig S.

Int J Cancer. 2017 Apr 15;140(8):1845-1849. doi: 10.1002/ijc.30605. Epub 2017 Feb 6.

7.

Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis.

Puig-Butille JA, Gimenez-Xavier P, Visconti A, Nsengimana J, Garcia-García F, Tell-Marti G, Escamez MJ, Newton-Bishop J, Bataille V, Del Río M, Dopazo J, Falchi M, Puig S.

Oncotarget. 2017 Feb 14;8(7):11589-11599. doi: 10.18632/oncotarget.14140.

8.

The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.

Tell-Marti G, Puig-Butille JA, Gimenez-Xavier P, Segu-Roig A, Potrony M, Badenas C, Alvarez V, Millán JM, Trujillo-Tiebas MJ, Ramos-Arroyo MA, Milà M, Puig S.

Mol Neurobiol. 2017 Jul;54(5):3906-3910. doi: 10.1007/s12035-016-0305-5. Epub 2016 Dec 6.

PMID:
27924526
9.

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.

Potrony M, Carreras E, Aranda F, Zimmer L, Puig-Butille JA, Tell-Martí G, Armiger N, Sucker A, Giménez-Xavier P, Martínez-Florensa M, Carrera C, Malvehy J, Schadendorf D, Puig S, Lozano F.

Int J Cancer. 2016 Sep 15;139(6):1297-302. doi: 10.1002/ijc.30184. Epub 2016 May 31.

10.

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer.

Romero OA, Setien F, John S, Gimenez-Xavier P, Gómez-López G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M.

EMBO Mol Med. 2012 Jul;4(7):603-16. doi: 10.1002/emmm.201200236. Epub 2012 Apr 11.

11.

Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model.

Giménez-Xavier P, Francisco R, Santidrián AF, Gil J, Ambrosio S.

Neurotoxicology. 2009 Jul;30(4):658-65. doi: 10.1016/j.neuro.2009.04.007. Epub 2009 May 4.

PMID:
19410601
12.

LC3-I conversion to LC3-II does not necessarily result in complete autophagy.

Giménez-Xavier P, Francisco R, Platini F, Pérez R, Ambrosio S.

Int J Mol Med. 2008 Dec;22(6):781-5.

PMID:
19020776
13.

Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells.

Gómez-Santos C, Francisco R, Giménez-Xavier P, Ambrosio S.

Neuroreport. 2007 Oct 29;18(16):1725-8.

PMID:
17921876
14.

Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines.

Francisco R, Pérez-Tomás R, Gimènez-Bonafé P, Soto-Cerrato V, Giménez-Xavier P, Ambrosio S.

Eur J Pharmacol. 2007 Oct 31;572(2-3):111-9. Epub 2007 Jul 4.

PMID:
17678643
15.

Intranigral dopamine toxicity and alpha-synuclein response in rats.

Gómez-Santos C, Giménez-Xavier P, Ferrer I, Ambrosio S.

Neurochem Res. 2006 Jul;31(7):861-8. Epub 2006 Jun 28.

PMID:
16804759
16.

The decrease of NAD(P)H has a prominent role in dopamine toxicity.

Giménez-Xavier P, Gómez-Santos C, Castaño E, Francisco R, Boada J, Unzeta M, Sanz E, Ambrosio S.

Biochim Biophys Acta. 2006 May;1762(5):564-74. Epub 2006 Mar 13.

17.

Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.

Gómez-Santos C, Barrachina M, Giménez-Xavier P, Dalfó E, Ferrer I, Ambrosio S.

Brain Res Bull. 2005 Feb 15;65(1):87-95.

PMID:
15680548

Supplemental Content

Loading ...
Support Center